Rapid European SARS-CoV-2 Emergency research Response

Grant number: 101003589

Grant search

Key facts

  • Disease

    COVID-19, Disease X
  • Start & end year

    2020
    2023
  • Known Financial Commitments (USD)

    $21,594,810.6
  • Funder

    European Commission
  • Principal Investigator

    GOOSSENS herman
  • Research Location

    Belgium
  • Lead Research Institution

    UNIVERSITEIT ANTWERPEN
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    N/A

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

RECoVER (Rapid European SARS-CoV-2 Emergency Research response) is a comprehensive research response to the SARS-CoV-2 outbreak addressing the most urgent questions for patient and public health level interventions. RECoVER originates from partners of the EU Framework 7 (FP7) funded PREPARE project (Platform for European Preparedness Against (Re-) emerging Epidemics. In RECoVER, we will address these urgent questions in a comprehensive, multidisciplinary and interacting set of research response activities, combing (i) clinical studies in primary and hospital care, (ii) epidemiological studies and modelling, and (iii) clinical biological studies. The proposed studies complement ongoing research in China, addressing key knowledge gaps and patient-cohort questions relevant to the European population. The research proposed includes essential needs for preparedness and response, even if circulation of the virus in Europe will be limited. RECoVER will inform future research response efforts to further strengthen Europe'Äôs and global clinical research preparedness to future emerging infectious diseases.

Publicationslinked via Europe PMC

Last Updated:43 minutes ago

View all publications at Europe PMC

Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial.

Multimodal SARS-CoV-2 interactome sketches the virus-host spatial organization.

Addressing current limitations of household transmission studies by collecting contact data.

Did aetiology matter in illness duration and complications in patients presenting in primary care with acute respiratory tract infections early in the COVID-19 pandemic: An observational study in nine countries.

Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study.

Coordination of COVID-19 platform trials in Europe.

SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity.

Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients.

Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes.